Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms

Recent advances in p53 research: an interdisciplinary perspective

(2008) M Olivier et al.   CANCER GENE THERAPY

TCTP protects from apoptotic cell death by antagonizing bax function

(2008) L Susini et al.   CELL DEATH AND DIFFERENTIATION

Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 Binding

(2008) Vanessa Lopez-Pajares et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting Polo-Like Kinase: Learning Too Little Too Late?

(2008) David Olmos et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

(2008) Michael D. Prados et al.   JOURNAL OF CLINICAL ONCOLOGY

The genetics of the p53 pathway, apoptosis and cancer therapy

(2008) Alexei Vazquez et al.   NATURE REVIEWS DRUG DISCOVERY

Plk1 depletion in nontransformed diploid cells activates the DNA-damage checkpoint

(2008) M Lei et al.   ONCOGENE

Drug discovery approaches targeting the PI3K/Akt pathway in cancer

(2008) C Garcia-Echeverria et al.   ONCOGENE

Tankyrase 1 and Tankyrase 2 Are Essential but Redundant for Mouse Embryonic Development

(2008) Y. Jeffrey Chiang et al.   PLoS One

Multiple pathways regulated by the tumor suppressor PP2A in transformation

(2008) Jukka Westermarck et al.   TRENDS IN MOLECULAR MEDICINE